ProShare Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-923
| Closed | -$17K | – | 1632 |
|
|
2016
Q1 | $17K | Sell |
923
-174
| -16% | -$3.21K | ﹤0.01% | 1575 |
|
|
2015
Q4 | $29K | Buy |
1,097
+379
| +53% | +$10K | ﹤0.01% | 1695 |
|
|
2015
Q3 | $33K | Sell |
718
-233
| -25% | -$10.7K | ﹤0.01% | 1419 |
|
|
2015
Q2 | $31K | Sell |
951
-505
| -35% | -$16.5K | ﹤0.01% | 1635 |
|
|
2015
Q1 | $46K | Sell |
1,456
-155
| -10% | -$4.9K | ﹤0.01% | 1875 |
|
|
2014
Q4 | $61K | Sell |
1,611
-1,375
| -46% | -$52.1K | ﹤0.01% | 1902 |
|
|
2014
Q3 | $79K | Sell |
2,986
-677
| -18% | -$17.9K | ﹤0.01% | 2207 |
|
|
2014
Q2 | $108K | Sell |
3,663
-2,390
| -39% | -$70.5K | ﹤0.01% | 2339 |
|
|
2014
Q1 | $224K | Buy |
+6,053
| New | +$224K | ﹤0.01% | 2445 |
|
|
2013
Q4 | – | Sell |
-3,780
| Closed | -$200K | – | 2111 |
|
|
2013
Q3 | $200K | Buy |
3,780
+303
| +9% | +$16K | ﹤0.01% | 2200 |
|
|
2013
Q2 | $186K | Buy |
+3,477
| New | +$186K | ﹤0.01% | 2066 |
|